Cite
HARVARD Citation
Hughes, M. et al. (2021). Accurate accounting of caplacizumab cost effectiveness – Authors' reply. Lancet. 8 (5), pp. e316-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hughes, M. et al. (2021). Accurate accounting of caplacizumab cost effectiveness – Authors' reply. Lancet. 8 (5), pp. e316-. [Online].